Kolkata Cancer Summit - 2027

About the Conference

The Kolkata Cancer Summit – 2027 is envisioned as a focused, high-level scientific meeting bringing together leading oncologists, cancer researchers, clinicians, surgeons, radiation specialists, pathologists, molecular scientists, academicians, and healthcare innovators to explore the rapidly changing landscape of cancer prevention, diagnosis, and treatment.

Organised as a flagship event of the World Cancer Congress, the Kolkata Cancer Summit will provide a dedicated platform for the oncology community of Eastern India to engage with emerging science, exchange clinical experience, and discuss the technologies and therapeutic approaches that are shaping the future of cancer care.

The Summit will place science at the centre of the programme, with particular emphasis on precision oncology, immunotherapy, antibody–drug conjugates, cellular therapies, liquid biopsy, ctDNA, artificial intelligence, early cancer detection, next-generation radiation, precision surgery, and advanced metastatic cancer management.

These areas reflect the direction in which contemporary cancer research is moving. Current major oncology programmes are giving substantial attention to precision medicine, CAR-T and mRNA-based approaches, AI, liquid biopsy, and emerging targeted therapies such as ADCs.

Focus of the Conference

Concentrating on what is changing in cancer care today—and what is likely to change it tomorrow.

• Precision Oncology: Molecular profiling, genomic biomarkers, NGS, personalised treatment strategies, and molecularly guided therapy.
• Immunotherapy: Next-generation immunotherapies, checkpoint inhibition, treatment resistance, tumour microenvironment, and novel immune-based approaches.
• Antibody–Drug Conjugates: The rapidly expanding role of ADCs and targeted therapeutics in modern cancer treatment regimens.
• Cellular Therapy & Cancer Vaccines: CAR-T, emerging cellular therapies, T-cell approaches, and personalised/mRNA cancer vaccines.
• Liquid Biopsy & ctDNA: Molecular monitoring, treatment response tracking, recurrence prediction, and minimal residual disease (MRD) detection.
• AI & Digital Oncology: AI-assisted diagnosis, digital pathology, advanced imaging, clinical decision support, and AI-enabled drug discovery.
• Early Detection & Prevention: Early detection technologies, screening protocols, molecular risk assessment, cancer interception, and precision prevention.
• Next-Gen Radiation Oncology: SBRT, FLASH radiotherapy, image-guided treatment, and advanced radiopharmaceutical/theranostic approaches.
• Precision Surgery: Robotic surgery, image-guided surgery, minimally invasive techniques, and organ preservation frameworks.
• Advanced & Metastatic Cancer: Oligometastatic disease, treatment resistance mitigation, tumour evolution, combination strategies, and long-term disease control.